EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial

Benjamin J Cowling iD, Sook-San Wong, Jefferson J S Santos, Lisa Touyon, Jordan T Ort, Naiqing Ye, Natalie K M Kwok, Faith Ho, Samuel M S Cheng, Dennis K M Ip, Malik Peiris, Richard J Webby und 6 weitere

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciae380 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Benjamin J Cowling und 17 weiteren Autor:innen. Beteiligte Einrichtung: WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of…. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Antibodies, Viral. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Research Grants Council of the Hong Kong SAR Government, National Institute of Allergy and Infectious Diseases, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies have reported that repeated annual vaccination may influence influenza vaccination effectiveness in the current season.

Methods

We established a 5-year randomized placebo-controlled trial of repeated influenza vaccination (Flublok; Sanofi Pasteur) in adults 18–45 years of age. In the first 2 years, participants were randomized to receive vaccine or saline placebo as follows: placebo-placebo (P-P), placebo-vaccine (P-V), or vaccine-vaccine (V-V). Serum samples were collected each year just before vaccination and after 30 and 182 days. A subset of serum samples collected at 5 time points from 95 participants were tested for antibodies against vaccine strains.

Results

From 23 October 2020 through 11 March 2021 we enrolled and randomized 447 adults. Among vaccinated individuals, antibody titers increased between days 0 and 30 against each of the vaccine strains, with smaller increases for repeat vaccinees who on average had higher prevaccination titers in year 2. There were statistically significant differences in the proportions of participants achieving ≥4-fold rises in antibody titer for the repeat vaccinees for influenza A(H1N1), B/Victoria, and B/Yamagata, but not for A(H3N2). Among participants who received vaccination in year 2, there were no significant differences between the P-V and V-V groups in geometric mean titers at day 30 or the proportions of participants with antibody titers ≥40 at day 30 for any of the vaccine strains.

Conclusions

In the first 2 years, during which influenza did not circulate, repeat and first-time vaccinees had similar postvaccination geometric mean titers to all 4 vaccine strains, indicative of similar levels of clinical protection. Clinical Trials Registration. NCT04576377

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanAntibodies, ViralHumansAdultMaleFemaleYoung AdultMiddle AgedAdolescentVaccinationInfluenza A Virus, H3N2 SubtypeVaccine EfficacyInfluenza A Virus, H1N1 SubtypeInfluenza B virus

Stichwörter der Autor:innen

ELISAantibodyimmunogenicityinfluenzavaccination

Substanzen

Influenza VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, New Territories, Hong Kong Special Administrative Region, China.
  • HKU-Pasteur Research Pole, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Gale and Ira Drukier Institute for Children's Health, Weill Cornell Medicine, New York, New York, USA.

ORCID-Profile: Benjamin J Cowling

Förderung

  • Research Grants Council of the Hong Kong SAR Government
  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • Theme-based Research Scheme
  • NCATS NIH HHS
  • NIH HHS

Zitieren

APA

Cowling, B. J., Wong, S. S., Santos, J. J. S., Touyon, L., Ort, J. T., Ye, N., Kwok, N. K. M., Ho, F., Cheng, S. M. S., Ip, D. K. M., Peiris, M., Webby, R. J., Wilson, P. C., Valkenburg, S. A., Tsang, J. S., Leung, N. H. L., Hensley, S. E., & Cobey, S. (2024). Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae380

Vancouver

Cowling BJ, Wong SS, Santos JJS, Touyon L, Ort JT, Ye N, et al. Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae380

BibTeX
@article{Cowling2024,
  author = {Cowling, Benjamin J and Wong, Sook-San and Santos, Jefferson J S and Touyon, Lisa and Ort, Jordan T and Ye, Naiqing and Kwok, Natalie K M and Ho, Faith and Cheng, Samuel M S and Ip, Dennis K M and Peiris, Malik and Webby, Richard J and Wilson, Patrick C and Valkenburg, Sophie A and Tsang, John S and Leung, Nancy H L and Hensley, Scott E and Cobey, Sarah},
  title = {Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciae380}
}
Kostenlos starten →